83 FR 3174 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 15 (January 23, 2018)

Page Range		3174-3174
FR Document		2018-01077

Federal Register, Volume 83 Issue 15 (Tuesday, January 23, 2018)

[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Notices]
[Page 3174]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-01077]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Epilepsy: Molecular Mechanisms.
    Date: January 24, 2018.
    Time: 3:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Suzan Nadi, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5217B, MSC 7846, Bethesda, MD 20892, 301-435-
1259, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 17, 2018.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-01077 Filed 1-22-18; 8:45 am]
 BILLING CODE 4140-01-P

3174 Federal Register / Vol. 83, No. 15 / Tuesday, January 23, 2018 / Notices

comments to be included at the meeting Contact Person: Suzan Nadi, Ph.D., Time: 10:00 a.m. to 3:15 p.m.
should also be sent to Lisa Kaeser by Scientific Review Officer, Center for Agenda: To review and evaluate grant
5:00 p.m. on Monday, February 19, Scientific Review, National Institutes of applications.
Health, 6701 Rockledge Drive, Room 5217B, Place: National Institutes of Health, 6701
2018.
MSC 7846, Bethesda, MD 20892, 301–435– Rockledge Drive, Bethesda, MD 20892.
The submitted presentations and any 1259, nadis@csr.nih.gov. Contact Person: Marie-Jose Belanger, Ph.D.,
written comments will be formatted to This notice is being published less than 15 Scientific Review Officer, Center for
be posted on the PRGLAC website for days prior to the meeting due to the timing Scientific Review, National Institutes of
the record. Only one representative of limitations imposed by the review and Health, 6701 Rockledge Drive, Rm 6188 MSC
an organization may be allowed to funding cycle. 7804, Bethesda, MD 20892, 301–435–1267,
present oral comments. Presentations (Catalogue of Federal Domestic Assistance belangerm@csr.nih.gov.
will be limited to three to five minutes Program Nos. 93.306, Comparative Medicine; Name of Committee: Genes, Genomes, and
per speaker depending on the number of 93.333, Clinical Research; 93.306, 93.333, Genetics Integrated Review Group;
speakers to be accommodated within 93.337, 93.393–93.396, 93.837–93.844, Therapeutic Approaches to Genetic Diseases
93.846–93.878, 93.892, 93.893, National Study Section.
the allotted time. Speakers will be Institutes of Health, HHS) Date: February 15, 2018.
assigned a time to speak in the order of Time: 10:00 a.m. to 7:00 p.m.
the date and time when their request to Dated: January 17, 2018.
Agenda: To review and evaluate grant
speak is received. Both printed and David Clary, applications.
electronic copies are requested for the Program Analyst, Office of Federal Advisory Place: National Institutes of Health, 6701
record. Committee Policy. Rockledge Drive, Bethesda, MD 20892
Details and additional information [FR Doc. 2018–01077 Filed 1–22–18; 8:45 am] (Virtual Meeting).
about these meetings can be found at the BILLING CODE 4140–01–P Contact Person: Methode Bacanamwo,
NICHD website for the Task Force on Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Research Specific to Pregnant Women Health, 6701 Rockledge Drive, Room 2200,
and Lactating Women (PRGLAC) DEPARTMENT OF HEALTH AND
Bethesda, MD 20892, 301–827–7088,
https://www.nichd.nih.gov/about/ HUMAN SERVICES methode.bacanamwo@nih.gov.
advisory/PRGLAC/Pages/index.aspx. Name of Committee: Center for Scientific
National Institutes of Health
Dated: January 17, 2018. Review Special Emphasis Panel; RFA–RM–
Michelle Trout, Center for Scientific Review; Notice of 17–029: Innovative Adaptations to Simplify
Closed Meetings Existing Technologies for Manipulation and
Analyst, Office of Federal Advisory
Analysis of Glycans.
Committee Policy.
Pursuant to section 10(d) of the Date: February 15, 2018.
[FR Doc. 2018–01082 Filed 1–22–18; 8:45 am] Time: 3:00 p.m. to 6:00 p.m.
Federal Advisory Committee Act, as
BILLING CODE 4140–01–P amended, notice is hereby given of the Agenda: To review and evaluate grant
following meetings. applications.
Place: National Institutes of Health, 6701
The meetings will be closed to the
DEPARTMENT OF HEALTH AND Rockledge Drive, Bethesda, MD 20892.
public in accordance with the Contact Person: Marie-Jose Belanger, Ph.D.,
HUMAN SERVICES provisions set forth in sections Scientific Review Officer, Center for
National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Scientific Review, National Institutes of
as amended. The grant applications and Health, 6701 Rockledge Drive, Rm 6188 MSC
Center for Scientific Review; Notice of the discussions could disclose 7804, Bethesda, MD 20892, 301–435–1267,
Closed Meeting confidential trade secrets or commercial belangerm@csr.nih.gov.
property such as patentable material, Name of Committee: Center for Scientific
Pursuant to section 10(d) of the and personal information concerning Review Special Emphasis Panel; PAR Panel:
Federal Advisory Committee Act, as individuals associated with the grant Screenable Disorders: Therapeutics, Tools
amended, notice is hereby given of the applications, the disclosure of which and Natural History.
following meeting. Date: February 16, 2018.
would constitute a clearly unwarranted
Time: 10:00 a.m. to 7:00 p.m.
The meeting will be closed to the invasion of personal privacy. Agenda: To review and evaluate grant
public in accordance with the Name of Committee: Oncology 2— applications.
provisions set forth in sections Translational Clinical Integrated Review Place: National Institutes of Health, 6701
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Group; Radiation Therapeutics and Biology Rockledge Drive, Bethesda, MD 20892
as amended. The grant applications and Study Section. (Virtual Meeting).
the discussions could disclose Date: February 12–13, 2018. Contact Person: Methode Bacanamwo,
confidential trade secrets or commercial Time: 8:00 a.m. to 5:00 p.m. Ph.D., Scientific Review Officer, Center for
property such as patentable material, Agenda: To review and evaluate grant Scientific Review, National Institutes of
and personal information concerning applications. Health, 6701 Rockledge Drive, Room 2200,
Place: Embassy Suites at the Chevy Chase Bethesda, MD 20892, 301–827–7088,
individuals associated with the grant
Pavilion, 4300 Military Road NW, methode.bacanamwo@nih.gov.
applications, the disclosure of which Washington, DC 20015. Name of Committee: Center for Scientific
would constitute a clearly unwarranted Contact Person: Bo Hong, Ph.D., Scientific Review Special Emphasis Panel;
invasion of personal privacy. Review Officer, Center for Scientific Review, Cardiovascular Disorders.
Name of Committee: Center for Scientific National Institutes of Health, 6701 Rockledge Date: February 21, 2018.
Review Special Emphasis Panel; Epilepsy: Drive, Room 6194, MSC 7804, Bethesda, MD Time: 10:00 a.m. to 7:00 p.m.
sradovich on DSK3GMQ082PROD with NOTICES

Molecular Mechanisms. 20892, 301–996–6208, hongb@csr.nih.gov. Agenda: To review and evaluate grant
Date: January 24, 2018. Name of Committee: Center for Scientific applications.
Time: 3:00 p.m. to 6:00 p.m. Review Special Emphasis Panel; RFA–RM– Place: National Institutes of Health, 6701
Agenda: To review and evaluate grant 17–030: Novel and Innovative Tools to Rockledge Drive, Bethesda, MD 20892
applications. Facilitate Identification, Tracking, (Virtual Meeting).
Place: National Institutes of Health, 6701 Manipulation, and Analysis of Glycans and Contact Person: Luis Espinoza, Ph.D.,
Rockledge Drive, Bethesda, MD 20892 their Functions. Scientific Review Officer, Center for
(Telephone Conference Call). Date: February 15, 2018. Scientific Review, National Institutes of

VerDate Sep<11>2014 17:59 Jan 22, 2018 Jkt 244001 PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 E:\FR\FM\23JAN1.SGM 23JAN1

Document Created: 2018-01-23 01:08:29
Document Modified: 2018-01-23 01:08:29

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		January 24, 2018.
FR Citation		83 FR 3174

83 FR 3174 - Center for Scientific Review; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 15 (January 23, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health